1. Hyperlactatemia in ICU patients: Incidence, causes and associated mortality.
- Author
-
Ferreruela M, Raurich JM, Ayestarán I, and Llompart-Pou JA
- Subjects
- Adult, Aged, Area Under Curve, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures mortality, Female, Hospital Mortality, Humans, Hyperlactatemia blood, Incidence, Lactic Acid blood, Male, Middle Aged, Predictive Value of Tests, ROC Curve, Retrospective Studies, Shock, Septic blood, Shock, Septic complications, Shock, Septic mortality, Survival Rate, Critical Illness mortality, Hyperlactatemia etiology, Hyperlactatemia mortality, Intensive Care Units
- Abstract
Purpose: To describe the incidence, causes and associated mortality of hyperlactatemia in critically ill patients and to evaluate the association between lactate clearance and in-hospital survival., Methods: Retrospective cohort study of patients with hyperlactatemia admitted to the ICU. Hyperlactatemia was defined as a blood lactate concentration ≥5mmol/L and high-grade hyperlactatemia a lactate level ≥10mmol/L. Lactate clearance was calculated as the percentage of decrease in lactate concentration from the peak value., Results: Of 10,123 patients, 1373 (13.6%) had lactate concentration ≥5mmol/L, and 434(31.6%) of them had ≥10mmol/L. The most common causes of hyperlactatemia were sepsis/septic shock and post-cardiac surgery. An association was found between lactate concentration and in-hospital mortality (p<0.001). The area under the receiver-operating-characteristics (ROC) of lactate concentration and the optimal cut off to predict mortality were 0.72 (0.70-0.75) and 8.6mmol/L, respectively. ROC analysis for lactate clearance to predict in-hospital survival showed that the best area under the curve was obtained at 12h: 0.67 (95% confidence interval 0.59-0.75)., Conclusions: Hyperlactatemia was common and associated with a high mortality in critically ill patients. Lactate clearance had limited utility for predicting in-hospital survival., (Copyright © 2017. Published by Elsevier Inc.)
- Published
- 2017
- Full Text
- View/download PDF